Bilcare Limited submitted a regulatory disclosure to the Bombay Stock Exchange under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

The disclosure concerns the change in designation of two directors following the outcome of the company's 39th Annual General Meeting held on 26 September 2026.

Background and Previous Communication

The company refers to its earlier letter dated 13 August 2026 which informed about the outcome of the Board Meeting held on 13 August 2026. That meeting had approved:

  • The appointment of Mr. Mohan Bhandari as an Executive Director
  • The reappointment of Ms. Kavita Bhansali as an Executive Director

Following the Board Meeting, the designations were updated on the BSE Portal accordingly.

AGM Outcome and Impact

Both special resolutions proposed in the 39th Annual General Meeting for these appointments were not passed by the requisite majority required for special resolutions.

As a result:

  • Mr. Mohan Bhandari continues only as Non-Executive Non-Independent Director & CEO of the Company
  • Ms. Kavita Bhansali continues only as Non-Executive Non-Independent Director of the Company

The disclosure serves to formally notify the exchange of these designation changes resulting from the failed special resolutions at the AGM.